- Life Sciences
Qualiber is a nanomedicine company spun-off from UNC-Chapel Hill. It has a differentiated drug delivery platform (nanoCLIPD) that has demonstrated application for cancer and other life threatening diseases. It’s lead product (NanoGTP) has significant potential in addressing the unmet needs of pancreatic and lung cancer patients. The company is founded and led by experienced management team with successful track record developing products for patients and generating value for investors and employees.